Editorial: Launching a dedicated collection on the intersection of cancer and heart diseases
-
By
-
Moez Karim Aziz
-
July 8, 2026
Clinical Report: Launching a dedicated collection on cancer and heart diseases
Overview
This editorial highlights the emerging field of cardio-oncology, emphasizing the overlap between cancer and cardiovascular diseases. It presents studies that explore the cardiovascular effects of cancer therapies.
Background
The intersection of cancer and cardiovascular disorders is increasingly recognized, with approximately 30% of cancer patients having comorbid cardiovascular disease. The establishment of the International Cardio-Oncology Society in 2009 addresses the cardiotoxic effects of oncologic therapies.
Data Highlights
No specific numerical data or trial results are provided in the editorial.
Key Findings
- 30% of cancer patients have comorbid cardiovascular disease.
- Doxorubicin can cause myocardial infarction due to coronary artery thrombosis.
- Hereditary cardiac myxomas are linked to PRKAR1A mutations, responsible for familial cases.
- Cardiac angiosarcoma management requires an interdisciplinary approach.
- Nutritional and inflammatory status are prognostic markers in oncologic patients.
- Trends indicate increased cardiotoxicity in patients treated for multiple myeloma.
Clinical Implications
Regular follow-up for cardiotoxic effects of chemotherapy and attention to nutritional status are components of care.
Conclusion
This editorial emphasizes the importance of research in the field of cardio-oncology.
Related Resources & Content
- Editorial, Basic Research in Cardiology, 2024 -- Launching a dedicated collection on cancer and heart diseases
- The ASCO Post — An Integrated Approach to Treating Cancer and Cardiovascular Disease: When Oncologists and Cardiologists Collaborate
- The ASCO Post — Cardiovascular Disease and Cancer: A Reciprocal Relationship?
- The ASCO Post — Cardio-oncology
- An Integrated Approach to Treating Cancer and Cardiovascular Disease
- Cardiovascular Disease and Cancer: A Reciprocal Relationship?
- 2022 ESC Guidelines on cardio-oncology
- Atorvastatin for Anthracycline-Associated Cardiac Dysfunction
- Scientific Publications on Cardio-Oncology
Based on findings from:
Editorial: introducing special collection on cancer and cardiovascular disorders
Moez Karim Aziz. Bmc Cardiovascular Disorders, 2026.
https://link.springer.com/article/10.1186/s12872-026-06181-1
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
